ACM Research Announces Participation in 13th Annual NYC Summit 2024
November 29, 2024 16:05 ET | Source: ACM Research, Inc. FREMONT, Calif.,…
Attruby (acoramidis), a Near Complete TTR Stabilizer (90%), approved by FDA to Reduce Cardiovascular Death and Cardiovascular-related Hospitalization in ATTR-CM Patients
- Attruby is the first and only approved product with a label…